iPSC-γδ NKT Cell Technology (gdNKT Therapy)
Induced pluripotent stem cells (iPSCs) are capable of self-renewing and differentiating into any cell types of the body. iPSCs represent an unlimited starting cell source to generate therapeutic cells of various functions. For cancer treatment, immune cells such as γδ T cells and NK cells are invaluable therapeutic cells since they naturally express an array of built-in receptors to recognize cancers.
By combining iPSC technology and directed differentiation, we are able to generate a novel type of synthetic immune cells, γδ NKT cells that express cancer recognition receptors of both γδ T cells and NK cells from iPSCs to recognize a wide range of cancers without genetic modification.
Why we start with iPSCs?
iPSCs provide an unlimited starting cell source to generate unlimited therapeutic cells
of various functions - our firsthand experience.
Why we generate γδ NKT cells?
To integrate more cancer recognition capabilities into one potent therapeutic product.
How we generate γδ NKT cells from iPSCs?
From γδ T cell to stem cells and back with more - our synthetic strategy of γδ NKT cells.
Proprietary differentiation protocol
γδ NKT cells
Unique product features of γδ NKT cells
Function of γδ NKT cells? γδ NKT cells are potent
γδ NKT cells in action
− γδ NKT cells killing colon cancer cells.
Seek, see and destroy
− unravelling the action of γδ NKT cells frame by frame.